Table 1: Sociodemographic, biological, and clinical characteristics of seropositive and seronegative subjects by gender.

HIV+HIV−
VariableMen ( )Women ( ) valueMen ( )Women ( ) value
Mean(SD)Mean(SD) Mean(SD)Mean(SD)

Age 34.17(5.33)33.42(5.06).01731.56(6.57)35.04(5.08).545
Years of education 9.32(2.42)10.45(3.18).26010.02(2.38) 9.66(2.49).238
CD4 cells per m3286.68(261.59)367.43(220.67)2.131

Variable No. (%)No.(%) No.(%) No.(%)

Manual dominanceRight 57(100.00) 31(93.94).048 16(88.88) 14(87.50).003
Left 0(0.00) 2(6.06) 2(11.12) 2(12.50)
DrugNever used drugs12(21.10) 10(30.03) .063 18(100.00) 16 (100.00).000
AbuseAbstinent IVDU*25(43.80) 8(24.24)
StatusMMP*20(35.10) 15(45.45)
Viral loadNot detectable14(24.60) 11(33.30)1.214
Low (<10,000) 19(33.30) 11(33.33)
Medium (from 10,000–30,000) 7(12.30) 3(9.09)
High (>30,000)17(29.80) 8(24.25)
Antiretroviral therapyReceiving 55(96,49) 32(96,96).000
Not receiving 2(3.51) 1(3,03)
Phase of infectionPhase A 16(28.10) 14(42.42)1.281
Phase B 13(22.80) 6(18.18)
Phase C28(49.10) 13(39.40)

* , ** .
*Note: IVDU: Intravenous Drug User; MMP: Methadone Maintenance Programme.